5:29 PM
 | 
Oct 24, 2012
 |  BC Extra  |  Financial News

Orexigen planning follow-on

Orexigen Therapeutics Inc. (NASDAQ:OREX) said late Wednesday it is planning a follow-on underwritten by Credit Suisse; BofA Merrill Lynch; and Leerink. Orexigen is evaluating the cardiovascular...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >